IL17A and breast cancer: In another mouse breast cancer model, the effects of interleukin (IL)-1β on the IL-17 expression of gamma delta (γδ) T cells were shown, affecting neutrophils and suppression of CD8 + T cells, also leading to the formation of metastases [7].